Rice Hall James & Associates LLC Decreases Position in TriMas Corporation $TRS

Rice Hall James & Associates LLC decreased its position in TriMas Corporation (NASDAQ:TRS) by 64.2% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 36,136 shares of the industrial products company’s stock after selling 64,756 shares during the period. Rice Hall James & Associates LLC’s holdings in TriMas were worth $1,299,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. AdvisorNet Financial Inc acquired a new position in shares of TriMas during the 1st quarter worth $28,000. Covestor Ltd boosted its position in shares of TriMas by 20,525.0% in the 4th quarter. Covestor Ltd now owns 825 shares of the industrial products company’s stock worth $29,000 after buying an additional 821 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in TriMas in the 4th quarter valued at about $29,000. Ball & Co Wealth Management Inc. acquired a new stake in TriMas in the 4th quarter valued at about $35,000. Finally, Rockefeller Capital Management L.P. increased its holdings in TriMas by 1,958.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,029 shares of the industrial products company’s stock valued at $36,000 after acquiring an additional 979 shares in the last quarter. Hedge funds and other institutional investors own 99.42% of the company’s stock.

Insider Buying and Selling at TriMas

In related news, Director Herbert K. Parker sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $45.03, for a total transaction of $675,450.00. Following the transaction, the director owned 57,762 shares of the company’s stock, valued at approximately $2,601,022.86. This represents a 20.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 17.50% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on TRS. Weiss Ratings raised shares of TriMas from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, June 23rd. Zacks Research upgraded TriMas from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 5th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $41.50.

Trending Headlines about TriMas

Here are the key news stories impacting TriMas this week:

• Positive Sentiment: Zacks Research raised its Q1 2027 EPS estimate for TriMas to $0.51 from $0.40, indicating improved expectations for near-term earnings power. TriMas stock page
• Neutral Sentiment: TriMas declared a quarterly dividend of $0.04 per share, payable August 13 to shareholders of record on August 6. The payout is small, with a modest yield of about 0.4%, so the announcement is unlikely to be a major driver of the stock. TriMas stock page
• Neutral Sentiment: TriMas is scheduled to report quarterly earnings soon, which may keep the stock active as investors look for confirmation of whether management can meet or beat the current full-year EPS consensus of $1.67. TriMas stock page
• Negative Sentiment: Zacks Research cut its Q2 2027 EPS estimate to $0.58 from $0.62, suggesting slightly weaker expectations for that period. TriMas stock page
• Negative Sentiment: The firm also reduced its Q3 2027 EPS estimate to $0.59 from $0.64 and its Q4 2027 estimate to $0.50 from $0.52, alongside a smaller trim to Q2 2028 EPS to $0.57 from $0.59. These downward revisions may pressure sentiment even though Zacks still rates the stock “Hold.” TriMas stock page

TriMas Price Performance

TRS opened at $40.03 on Monday. The firm has a market cap of $1.43 billion, a P/E ratio of 1.66 and a beta of 0.59. The business’s fifty day simple moving average is $41.20 and its 200 day simple moving average is $38.26. TriMas Corporation has a 52 week low of $30.43 and a 52 week high of $45.42. The company has a quick ratio of 4.50, a current ratio of 4.85 and a debt-to-equity ratio of 0.27.

TriMas (NASDAQ:TRS) last announced its earnings results on Thursday, April 30th. The industrial products company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.48 by ($0.24). The firm had revenue of $168.28 million during the quarter, compared to analyst estimates of $158.24 million. TriMas had a net margin of 93.79% and a return on equity of 8.38%. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 EPS. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS. As a group, equities research analysts anticipate that TriMas Corporation will post 1.67 EPS for the current fiscal year.

TriMas Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 13th. Stockholders of record on Thursday, August 6th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Thursday, August 6th. TriMas’s payout ratio is currently 0.66%.

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.